Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) CEO Jacob Chacko sold 13,958 shares of the company’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $12.12, for a total transaction of $169,170.96. Following the completion of the sale, the chief executive officer now owns 794,586 shares […]
Shares of ADC Therapeutics SA (NYSE:ADCT – Get Free Report) have earned an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy […]
Bleakley Financial Group LLC boosted its stake in Humana Inc. (NYSE:HUM – Free Report) by 1.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,638 shares of the insurance provider’s stock after acquiring an additional 211 shares during the quarter. Bleakley Financial […]
Prosight Management LP bought a new position in shares of Medtronic plc (NYSE:MDT – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 60,000 shares of the medical technology company’s stock, valued at approximately $5,286,000. Medtronic accounts for about 1.6% […]